Objectives

The overarching goal of AVITHRAPID is to develop novel broad-spectrum antivirals providing additional therapeutic options for current and future epidemics and pandemics based on existent substances with proven efficacy against drug targets using a rational pre-clinical drug discovery workflow.

By coordinating cutting-edge capacities and expertise already available in Europe AVITHRAPID will focus on specific objectives:

  • Supporting pandemic preparedness by provision of novel approaches for the development of antivirals using sophisticated computational methods in combination with experimental validation.
  • Joint development and optimization of pre-clinical candidates based on an available set of small molecules addressing various viral targets with a focus on broad-spectrum applicability
  • Establish a complete pre-clinical drug discovery pipeline based on the research activities within AVITHRAPID, that allows to react rapidly in case of novel viral infections with pandemic potential.

We use cookies to provide you with the best possible experience on our website.